Peptide Cancer Vaccine Market Size, Share & Trends Analysis By Type (Multivalent Peptide Vaccine, Personalized Peptide Vaccine, Peptide Cocktail Type, Hybrid Peptide Vaccine, Peptide-Pulsed Dendritic Cancer Vaccine), By Application (Breast Cancer, Prostate Cancer, Lung Cancer, Melanoma), by Region, And by Segment Forecasts, 2025-2034.

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Peptide Cancer Vaccine Market Snapshot Chapter 4. Global Peptide Cancer Vaccine Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Porter's Five Forces Analysis 4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034 4.8. Global Peptide Cancer Vaccine Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034 4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024) 4.10. Use/impact of AI on Peptide Cancer Vaccine Market Industry Trends Chapter 5. Peptide Cancer Vaccine Market Segmentation 1: By Type, Estimates & Trend Analysis 5.1. Market Share by Type, 2024 & 2034 5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type: 5.2.1. Multivalent Peptide Vaccine 5.2.2. Peptide Cocktail Type 5.2.3. Personalized Peptide Vaccine 5.2.4. Peptide-Pulsed Dendritic Cancer Vaccine 5.2.5. Hybrid Peptide Vaccine Chapter 6. Peptide Cancer Vaccine Market Segmentation 2: By Application, Estimates & Trend Analysis 6.1. Market Share by Application, 2024 & 2034 6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application: 6.2.1. Breast Cancer 6.2.2. Lung Cancer 6.2.3. Melanoma 6.2.4. Prostate Cancer Chapter 7. Peptide Cancer Vaccine Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. Global Peptide Cancer Vaccine Market, Regional Snapshot 2024 & 2034 7.2. North America 7.2.1. North America Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034 7.2.1.1. US 7.2.1.2. Canada 7.2.2. North America Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Type, 2021-2034 7.2.3. North America Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034 7.3. Europe 7.3.1. Europe Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034 7.3.1.1. Germany 7.3.1.2. U.K. 7.3.1.3. France 7.3.1.4. Italy 7.3.1.5. Spain 7.3.1.6. Rest of Europe 7.3.2. Europe Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Type, 2021-2034 7.3.3. Europe Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034 7.4. Asia Pacific 7.4.1. Asia Pacific Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034 7.4.1.1. India 7.4.1.2. China 7.4.1.3. Japan 7.4.1.4. Australia 7.4.1.5. South Korea 7.4.1.6. Hong Kong 7.4.1.7. Southeast Asia 7.4.1.8. Rest of Asia Pacific 7.4.2. Asia Pacific Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Type, 2021-2034 7.4.3. Asia Pacific Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034 7.5. Latin America 7.5.1. Latin America Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034 7.5.1.1. Brazil 7.5.1.2. Mexico 7.5.1.3. Rest of Latin America 7.5.2. Latin America Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Type, 2021-2034 7.5.3. Latin America Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034 7.6. Middle East & Africa 7.6.1. Middle East & Africa Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by country, 2021-2034 7.6.1.1. GCC Countries 7.6.1.2. Israel 7.6.1.3. South Africa 7.6.1.4. Rest of Middle East and Africa 7.6.2. Middle East & Africa Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Type, 2021-2034 7.6.3. Middle East & Africa Peptide Cancer Vaccine Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Imugene 8.2.1.1. Business Overview 8.2.1.2. Key Type/Service 8.2.1.3. Financial Performance 8.2.1.4. Geographical Presence 8.2.1.5. Recent Developments with Business Strategy 8.2.2. Generex Biotechnology 8.2.3. BrightPath Biotherapeutics 8.2.4. Sellas 8.2.5. TapImmune 8.2.6. OncoTherapy Science 8.2.7. VAXON Biotech 8.2.8. Boston Biomedical 8.2.9. Ultimovacs 8.2.10. Immatics 8.2.11. ISA Pharmaceuticals 8.2.12. Others